Advertisement
ProteinSimple
ProteinSimple

Paper Retracted Following Lawsuit

Research funded in part by a biotech was retracted after a lawsuit claiming the work could not be replicated.

By | January 5, 2012

Prostate CancerWIKIMEDIA COMMONS, NEPHRON

Robert Getzenberg of Johns Hopkins University retracted his finding published in Urology on a novel blood protein that could be developed into a test for prostate cancer, after reviewing the original data and finding inconsistencies in the reported results.

The research had come under scrutiny because Onconome, a company that had in part funded the work, tried to develop the results into a diagnostic and failed, reported ScienceInsider.  They found that the biomarker was "essentially as reliable as flipping a coin," according to the Onconome’s lawsuit against Johns Hopkins, Getzenberg, and Getzenberg’s former employer, the University of Pittsburgh.

While the lawsuit was settled in 2010, the research was only retracted in October 2011, after it had been cited 67 times, according to Retraction Watch.

(Read more about the problem with cancer biomarkers.)

Advertisement
ASM
ASM

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: jhnycmltly

jhnycmltly

Posts: 65

January 8, 2012

At least someone caught THIS 'test for cancer'. It wasn't too long ago there was a test being USED that was found to be veritably useless.

Avatar of:

Posts: 0

January 8, 2012

At least someone caught THIS 'test for cancer'. It wasn't too long ago there was a test being USED that was found to be veritably useless.

Avatar of:

Posts: 0

January 8, 2012

At least someone caught THIS 'test for cancer'. It wasn't too long ago there was a test being USED that was found to be veritably useless.

Advertisement
BD Biosciences
BD Biosciences

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies